论文部分内容阅读
海龙药用始载于清·赵学敏《本草纲目拾遗》,“产澎湖澳,冬日双跃海滩,渔人获之,号为珍物,首尾似龙,无牙爪,长尺余。”从上看出它产在我国东海与南海一带,并从长尺余可推知它为刁海龙Solenognathus hard-wichii(Gray),因为在我国已见记载的十二种海龙中,只有它的体长在一尺(33.33cm)以上,其余均在30cm以下。过去,中药海龙除来源于刁海龙外,还用拟海龙Sy-ngathoides biaculeatua (Bloch),六十年代初
Hailong medicinal use was first published in Qing Zhao Xuemin’s “Compendium of Compendium of Materia Medica”, “producing Luhu Lake and Macao, and the beach is double-leaping in the winter. The fishermen get it, and they are known as rare objects, with dragons and tails like dragons, no claws and long feet.” It is produced in the East China Sea and the South China Sea, and it can be inferred from the long rule that it is the sea bream Solenognathus hard-wichii (Gray), because of the 12 species of sea dragons that have been recorded in China, only its body length is a foot. Above (33.33cm), the rest are all below 30cm. In the past, Chinese medicine dragons originated from the Bohai Sea Dragons, but also used the Sy-ngathoides biaculeatua (Bloch) in the early sixties.